Iridex (IRIX) Net Cash Flow Growth (1y) (2012 - 2026)
Iridex (IRIX) Net Cash Flow Growth (1y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | -562.77% |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | 2,827.78% |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | 10.50% |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | -395.56% |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | 168.38% |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | -103.49% |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | -114.85% |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | -215.59% |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | -54.17% |
| 10 | Iridex | 13.09 Mn | 8.41 Mn | 4.30 Mn | 120.28% |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 4, 2026 | -129.45% |
| Jan 3, 2026 | 131.13% |
| Sep 27, 2025 | -380.08% |
| Jun 28, 2025 | 68.02% |
| Mar 29, 2025 | 395.52% |
| Dec 28, 2024 | -62.42% |
| Sep 28, 2024 | 86.71% |
| Jun 29, 2024 | -8.69% |
| Mar 30, 2024 | 42.05% |
| Dec 30, 2023 | 46.08% |
| Sep 30, 2023 | 13.75% |
| Jul 1, 2023 | 55.52% |
| Apr 1, 2023 | 12.95% |
| Dec 31, 2022 | -113.10% |
| Apr 2, 2022 | -120.08% |
| Apr 3, 2021 | 1,170.45% |
| Sep 26, 2020 | 113.84% |
| Jun 27, 2020 | 132.78% |
| Mar 28, 2020 | 62.42% |
| Dec 28, 2019 | 89.00% |